Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions Source: Eur Respir J 2004; 24: Suppl. 48, 699s Year: 2004
Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial). Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC). Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Regional laser centre experience in bronchoscopic photodynamic therapy (PDT) in inoperable bronchopulmonary cancer Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002
Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Endoscopical laser treatment in combined therapy non small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015
Photodynamic therapy for endoscopically early hilar lung cancer using diode laser and talaporfin sodium (laserphyrin) Source: Annual Congress 2008 - Hot and cold techniques Year: 2008
Induction chemotherapy (IC) followed by surgery (S) for advanced non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers Source: Eur Respir J 2006; 28: 200-218 Year: 2006
An open label pilot study of tumor treating fields (TTFields) in combination with pemetrexed (Pem) for advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
The comparison of paclitaxel-carboplatin (PCp) versus gemcitabine-cisplatin (GC) in the treatment of locally advanced or metastatic non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002
Docetaxel (DOC) and gemcitabine (GEM) consist a safe and effective combination in the management of non-small cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 30s Year: 2003
Radioiodine therapy (RAI) and lung function in differentiated thyroid cancer (DTC) Source: Eur Respir J 2005; 26: Suppl. 49, 524s Year: 2005
Single institution experience in advanced non-small cell lung cancer (NSCLC) patients (pts) with erlotinib (Tarceva®) within a large extended access programme* (EAP) Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006
Endoscopic management of early lung cancer: HFEC, cryo, brachy, PDT, YAG; the pulmonologist’s view Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care. Source: International Congress 2019 – Treatment of lung cancer Year: 2019
How to predict fatal pneumonitis in non-small cell lung cancer (NSCLC) patients treated with radiotherapy (RT) Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018